ABSTRACT
Objective:
This study was conducted to investigate the relationship between platelet count, mean platelet volume (MPV), platelet distribution width (PDW), C-reactive protein (CRP), platelet/lymphocyte ratio (PLR), neutrophil/lymphocyte ratio (NLR), systemic immune-inflammation index (SII) and osteoporosis (OP) in postmenopausal women.
Materials and Methods:
Four hundred eighty two patients who had been in menopause for at least 2 years were included in our study. Hemogram, CRP, thyroid-stimulating hormone (TSH), parathyroid hormone, 25-hydroxyvitamin D3 vitamin and dual-energy X-ray absorptiometry results of all patients were recorded. Two hundred ninety five patients with L2-L4 and/or femoral neck T-scores ≤-2.5 were determined as the OP group, and 192 patients with L2-L4 and/or Femoral neck T-scores ≥-1.0 were determined as the control group. NLR, PLR and SII were calculated and recorded from the hemogram results.
Results:
The mean age of the OP group was 64.2±8.3 years, and the mean age of the control group was 56.6±8.7. Age and vitamin D3 levels were higher in the OP group than in the control group (p<0.001). Leukocytes, neutrophil and MPV levels were found to be lower in the OP group than in the control group (p<0.005). While the L2-L4 T-score was negatively correlated with age and vitamin D3; leukocytes, MPV, PDW, TSH and CRP were positively correlated. The femoral neck T-score was negatively correlated with age and vitamin D3, whereas it was positively correlated with MPV, PDW, TSH and CRP.
Conclusion:
Platelet functions and immune system markers are effective in bone mineralization in postmenopausal OP patients.
References
1
Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005;115:3318-25.
2
Vlot MC, den Heijer M, de Jongh RT, Vervloet MG, Lems WF, de Jonge R, et al. Clinical utility of bone markers in various diseases. Bone 2018;114:215-25.
3
Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol 2017;5:908-23.
4
Wang L, Hu YQ, Zhao ZJ, Zhang HY, Gao B, Lu WG, et al. Screening and validation of serum protein biomarkers for early postmenopausal osteoporosis diagnosis. Mol Med Rep 2017;16:8427-33.
5
Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. Bone 2005;36:812-9.
6
Ciovacco WA, Goldberg CG, Taylor AF, Lemieux JM, Horowitz MC, Donahue HJ, et al. The role of gap junctions in megakaryocyte-mediated osteoblast proliferation and differentiation. Bone 2009;44:80-6.
7
Kacena MA, Nelson T, Clough ME, Lee SK, Lorenzo JA, Gundberg CM, et al. Megakaryocyte-mediated inhibition of osteoclast development. Bone 2006;39:991-9.
8
D›Amelio P, Cristofaro MA, De Vivo E, Ravazzoli M, Grosso E, Di Bella S, et al. Platelet vitamin D receptor is reduced in osteoporotic patients. Panminerva Med 2012;54:225-31.
9
Su X, Floyd DH, Hughes A, Xiang J, Schneider JG, Uluckan O, et al. The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling. J Clin Invest 2012;122:3579-92.
10
Cure MC, Cure E, Kirbas A, Cicek AC, Yuce S. The effects of Gilbert’s syndrome on the mean platelet volume and other hematological parameters. Blood Coagul Fibrinolysis 2013;24:484-8.
11
Liu R, Gao F, Huo J, Yi Q. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease. Platelets 2012;23:11-6.
12
De Luca G, Venegoni L, Iorio S, Secco GG, Cassetti E, Verdoia M, et al. Platelet distribution width and the extent of coronary artery disease: results from a large prospective study. Platelets 2010;21:508-14.
13
Li XS, Zhang JR, Meng SY, Li Y, Wang RT. Mean platelet volume is negatively associated with bone mineral density in postmenopausal women. J Bone Miner Metab 2012;30:660-5.
14
Yan P, Xu Y, Wan Q et al. Impact of MPV and PDW on bone mineral density and their relationship with osteoporosis in Chinese patients with type 2 diabetes. Int J Clin Exp Med 2018;11:2337-49.
15
Cure E, Balik MS, Cumhur Cure M, Guvercin Y, Erkut A, Yuce S, et al. Is the mean platelet volume predictive of hip fractures in the elderly? Ann Lab Med 2013;33:367-70.
16
Akbal A, Gökmen F, Gencer M, Inceer BS, Kömürcü E. Mean platelet volume and platelet distribution width can be related to bone mineralization. Osteoporos Int 2014;25:2291-5.
17
Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 2011;107:433-8.
18
Huang Y, Deng W, Zheng S, Feng F, Huang Z, Huang Q, et al. Relationship between monocytes to lymphocytes ratio and axial spondyloarthritis. Int Immunopharmacol 2018;57:43-6.
19
Ommen SR, Gibbons RJ, Hodge DO, Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol 1997;79:812-4.
20
Azab B, Jaglall N, Atallah JP, Lamet A, Raja-Surya V, Farah B, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology 2011;11:445-52.
21
Xiang J, Zhou L, Li X, Bao W, Chen T, Xi X, et al. Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer. Transl Oncol 2017;10:33-9.
22
Öztürk ZA, Yesil Y, Kuyumcu ME, Bilici M, Öztürk N, Yeşil NK, et al. Inverse relationship between neutrophil lymphocyte ratio (NLR) and bone mineral density (BMD) in elderly people. Arch Gerontol Geriatr 2013;57:81-5.
23
Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010;106:470-6.
24
Song S, Li C, Li S, Gao H, Lan X, Xue Y. Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer. Onco Targets Ther 2017;10:3145-54.
25
Ma M, Luo S, Zhou W, Lu L, Cai J, Yuan F, et al. Bioinformatics analysis of gene expression profiles in B cells of postmenopausal osteoporosis patients. Taiwan J Obstet Gynecol 2017;56:165-70.
26
Weitzmann MN, Ofotokun I. Physiological and pathophysiological bone turnover - role of the immune system. Nat Rev Endocrinol 2016;12:518-32.
27
Oka R, Ohira M, Suzuki S, Yoshida T, Koide H, Tanaka T, et al. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey. Endocr J 2018;65:193-202.
28
Berglundh S, Malmgren L, Luthman H, McGuigan F, Åkesson K. C-reactive protein, bone loss, fracture, and mortality in elderly women: a longitudinal study in the OPRA cohort. Osteoporos Int 2015;26:727-35.
29
Lim HS, Park YH, Kim SK. Relationship between Serum Inflammatory Marker and Bone Mineral Density in Healthy Adults. J Bone Metab 2016;23:27-33.
30
Huang C, Li S. Association of blood neutrophil lymphocyte ratio in the patients with postmenopausal osteoporosis. Pak J Med Sci 2016;32:762-5.
31
Fisher A, Srikusalanukul W, Fisher L, Smith P. The Neutrophil to Lymphocyte Ratio on Admission and Short-Term Outcomes in Orthogeriatric Patients. Int J Med Sci 2016;13:588-602.
32
Fang H, Zhang H, Wang Z, Zhou Z, Li Y, Lu L. Systemic immune-inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture. J Clin Lab Anal 2020;34:e23016.
33
Eroglu S, Karatas G. Platelet/lymphocyte ratio is an independent predictor for osteoporosis. Saudi Med J 2019;40:360-6.
34
Zhong JH, Huang DH, Chen ZY. Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis. Oncotarget 2017;8:75381-8.
35
Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis. Circ Res 2018;122:337-51.
36
Oei L, Campos-Obando N, Dehghan A, Oei EH, Stolk L, van Meurs JB, et al. Dissecting the relationship between high-sensitivity serum C-reactive protein and increased fracture risk: the Rotterdam Study. Osteoporos Int 2014;25:1247-54.
37
Miyamoto K, Yoshida S, Kawasumi M, Hashimoto K, Kimura T, Sato Y, et al. Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. J Exp Med 2011;208:2175-81.
38
Ciovacco WA, Cheng YH, Horowitz MC, Kacena MA. Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation. J Cell Biochem 2010;109:774-81.
39
Kim J, Kim HS, Lee HS, Kwon YJ. The relationship between platelet count and bone mineral density: results from two independent population-based studies. Arch Osteoporos 2020;15:43.
40
Lemieux JM, Horowitz MC, Kacena MA. Involvement of integrins alpha(3)beta(1) and alpha(5)beta(1) and glycoprotein IIb in megakaryocyte-induced osteoblast proliferation. J Cell Biochem 2010;109:927-32.
41
Özkaya DB, Küçük ÖS, Onsun N. Comparing Mean Platelet Volume Values in Patients with Recurrent Aphthous Stomatitis and Patients with Behcet›s Disease. Bezmialem Science 2019;6:196-9.
42
Cartwright J, Duncan WC, Critchley HO, Horne AW. Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities. Reproduction 2009;138:9-22.